Search Results - J. McIntyre

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Functional limitations and coping mechanisms of women aged 60 years and older with self-reported hand osteoarthritis

    Functional limitations and coping mechanisms of women aged 60 years and older with self-reported hand osteoarthritis by J. McIntyre, R.W.E. Joubert, S.S. Ramklass

    Published 2014-11-01

    Background: Hand osteoarthritis (HOA) is common in older women who seem to cope with the associated limitations in hand function. The importance of identifying coping mechanisms within a local context might have implications for intervention, especially with the introduction of National Health Insur...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive... by Frankie Ann Holmes, Beth A. Hellerstedt, John E. Pippen Jr., Svetislava J. Vukelja, Rufus P. Collea, Darren M. Kocs, Joanne L. Blum, Kristi J. McIntyre, Minal A. Barve, Barry D. Brooks, Cynthia R. Osborne, Yunfei Wang, Lina Asmar, Joyce O'Shaughnessy

    Published 2018-06-01

    Abstract We aimed to increase pathologic complete response (pCR) in patients with invasive breast cancer by adding preoperative capecitabine to docetaxel following 5‐fluorouracil, epirubicin, cyclophosphamide (FEC) (with trastuzumab for patients with HER2‐positive disease) and to evaluate 5‐year dis...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: